Navigation Links
Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine
Date:5/22/2013

PASADENA, Calif., May 22, 2013 /PRNewswire/ -- The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published today in Vaccine.

The U.S. Food and Drug Administration approved PCV13 for use beginning in 2010 after a series of trials. These trials found that PCV13, which protects against a broader range of pneumococcal types than the previously used PCV7, did not increase the risk for any serious adverse events related to the vaccine.

In a study funded by the Centers for Disease Control and Prevention, Kaiser Permanente researchers evaluated the electronic medical records of nearly 600,000 children, ages 1 month to 2 years, who received PCV13 over a two-year period. Comparing the number of rare adverse events associated with the PCV13 vaccine to the number of events associated with the previously used PCV7 vaccine, the study authors found there were no increased risks for any of the following pre-specified conditions: febrile seizures, encephalopathy (a type of brain disorder), hives/angioedema, asthma, low platelet counts or systemic allergic reactions.

"It is important that children receive the pneumococcal conjugate vaccine as it provides protection against very serious and potentially fatal infections, including meningitis and bloodstream infections. The new vaccine protects against an additional six types of pneumococcal bacteria," said study lead author Hung Fu Tseng , PhD, MPH, a research scientist at the Kaiser Permanente Southern California Department of Research & Evaluation.

Early in the study, there was a statistically significant but very small increase in the risk of Kawasaki's disease, a rare condition in children that causes inflammation of the blood vessels, associated with PCV1
'/>"/>

SOURCE Kaiser Permanente
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kaiser Permanente Ranks Highest in 2012 J.D. Power and Associates Employer Satisfaction Study for Second Year in a Row
2. My Health Manager Users More Likely to Remain Kaiser Permanente Members
3. Four Million People Choose Connectivity and Convenience with Kaiser Permanentes Personal Health Record
4. Kaiser Permanente Appoints Alexandra Morehouse as Vice President of Advertising and Brand Management
5. Kaiser Permanente Joins Rock Health to Support Digital Innovation in Health Care
6. Jack Cochran, MD, Executive Director of The Permanente Federation at Kaiser Permanente, named to National Quality Forum Board
7. Kaiser Permanente Members Share Stories of Survival for Februarys Heart Health Month
8. Kaiser Permanente Receives Award for Excellence in Medication Safety
9. Doug Bonacum of Kaiser Permanente Named to List of 50 Experts Leading the Field of Patient Safety
10. Nearly 30 Percent of Women Fail to Pick Up New Prescriptions for Osteoporosis, Kaiser Permanente Study Finds
11. Kaiser Permanente Study Finds Varied Reasons Why Patients Do Not Fill their Initial Statin Prescriptions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... BERLIN , April 28, 2015 ... universities of Berlin and the ... Berlin as a central research location ... of scientific, technical and medical information products and services, ... Charité, the Humboldt University (Humboldt-Universität), the Free University ...
(Date:4/28/2015)... , April 28, 2015 ANI Pharmaceuticals, Inc. ... plans to release its first quarter 2015 financial results ... the U.S. financial markets. The earnings press release will ... Company,s website, www.anipharmaceuticals.com . ... and Charlotte C. Arnold , Vice President and ...
(Date:4/28/2015)... , April 28, 2015 /CNW/ - The group representing the ... drug tragedy left a two-hour meeting with Health Canada ... March 6th, Health Canada announced a $180 million support ... than six weeks after the Health Canada announcement and ... fully support the victims, the group representing ...
Breaking Medicine Technology:Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 2Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 3ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results 2Thalidomide Victims Gravely Concerned by Health Canada's Silence 2
... control versus Concerta from 30 minutes to six hours post-dose in ... as 30 minutes post-dose, - Additional analysis suggests Focalin XR provides comparable efficacy ... Concerta ... impact a child,s ability to focus and learn in an educational ...
... ANA773 Acting via ... ... July 7 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ) announced today ... for the,treatment of chronic hepatitis C. Based on preclinical pharmacology testing,and ...
Cached Medicine Technology:Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 3Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 4Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 5Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 6Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 7Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 8Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5
(Date:4/28/2015)... NY (PRWEB) April 28, 2015 ... management (IdM/IAM) solutions, announces today that they have ... of the top ten Identity and Access Management ... of the top Identity and Access Management tools ... quarter of 2015 and analyzed their trends to ...
(Date:4/28/2015)... 28, 2015 A new survey from ... lung damage, 66 percent of Americans fear brain damage the ... Awareness Month in May, shed light on the need for ... help prevent a stroke. By controlling modifiable risk factors, ... stroke is a “ brain attack ” that occurs when ...
(Date:4/28/2015)... CA (PRWEB) April 28, 2015 ... the Journal of Molecular Imaging and Biology showed ... a 2nd generation fluorine-18 labeled small-molecule PSMA inhibitor. ... Hopkins University in Baltimore, MD by study co-author, ... initial human evaluation of [18F]DCFPyL demonstrated a number ...
(Date:4/28/2015)... Colorado spine surgeon Donald Corenman, MD, DC has ... education website NECKANDBACK.COM and his back pain ... website has been redesigned to help patients gain a ... of neck and back pain, and conditions and treatments ... answers questions in the neck and back pain forum ...
(Date:4/28/2015)... Everett, WA (PRWEB) April 28, 2015 Dead ... for owners and their property. In many cases, tree removal ... most efficient way to eliminate the threat. , ... various types of tree removal available to property owners today. ... can provide for a job well done. , The article ...
Breaking Medicine News(10 mins):Health News:Tools4ever Chosen as Part of “Top Identity and Access Management Tools - 2015 Edition” 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3Health News:Tree Removal Methods and Services Discussed in Recent Article by Precision Tree Services 2
... , LONDON, July 13 The market for most ... sales are geared towards the replacement of older systems. Global conglomerates, ... dominate the market. However, there are many small regional vendors that ... in Europe. Innovation will be critical for success in this market. ...
... 13 Uroplasty, Inc. (NYSE Amex: UPI ... markets innovative proprietary products for the treatment of voiding ... No. 7,536,226 entitled, "Electro-Nerve Stimulator System and Methods." The ... methods for treatment of the overactive bladder ("OAB") symptoms ...
... , BEVERLY HILLS, Calif., July 13 Michael Jackson,s ... across America via top TV networks, thanks to PR Whiz Belinda ... joined forces via world media outlets strategized by PR Whiz, Foster, ... drug addict, but rather a chronic insomniac. , ...
... ... , ... 13, 2009 -- Upsher-Smith announces updates to its Website, www.prenexa.com . PreNexa® is the ... prenatal vitamins taken once a day.(1-4) , ,The updated content and offerings on prenexa.com ...
... ... ... 2009 -- Omnetics Connector Corporation , the leading manufacturer of nano-miniature ruggedized connectors, ... miniature electrical connectors. Their proprietary process of terminating signals and grounds on separate ...
... ... and Technology at Online Radiology Medical Group, Inc. (ONRAD), is excited to announce the launch ... ... and Technology at Online Radiology Medical Group, Inc. (ONRAD), is excited to announce the launch ...
Cached Medicine News:Health News:Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & Sullivan 2Health News:Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders, Advises Frost & Sullivan 3Health News:Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System 2Health News:Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System 3Health News:PR Whiz Belinda Foster Launches Michael Jackson's Nurse, Cherilyn Lee, on World Media Campaign 2Health News:Upsher-Smith Laboratories, Inc. Updates Prenexa.com with Folic Acid Content, Money-Saving Coupon, and Personalized Address Labels 2Health News:Omnetics' Multi-Contact Nano Connectors Obtain Digital Transmission Rates Over 2 Gb/sec. 2
... PRODUCT SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ... (3%): less than or equal to 35C Remelt Point ... (3%): greater than or equal to 300 gm/cm 2 ... less than or equal to 0.10% DNase: Passes test ...
... Form: Granular, free-flowing powder EEO(-m r ): less ... less than or equal to 35.5C Remelt Point (3%): ... (1.5%): greater than or equal to 600 gm/cm ... or equal to 1500 gm/cm 2 Moisture: ...
... traces: chloride (Cl) ≤ 500 mg/kg sulfate (SO 4 ... mg/kg Cd ≤ 5 mg/kg Co ≤ 5 mg/kg ... ≤ 10 mg/kg K ≤ 50 mg/kg Mg ≤ ... mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 mg/kg ...
... Anion traces: chloride (Cl) ≤ 3000 mg/kg sulfate (SO ... 500 mg/kg Cd ≤ 10 mg/kg Co ≤ 10 ... Fe ≤ 10 mg/kg K ≤ 500 mg/kg Mg ... 5000 mg/kg Ni ≤ 10 mg/kg Pb ≤ 10 ...
Medicine Products: